Evidence map›Paper›PMID 29899230›Full record

ArticleMolecules (Basel, Switzerland)2018

Hydroxyl Group and Vasorelaxant Effects of Perillyl Alcohol, Carveol, Limonene on Aorta Smooth Muscle of Rats.

Ana Carolina Cardoso-Teixeira, Francisco Walber Ferreira-da-Silva, Dieniffer Peixoto-Neves, Klausen Oliveira-Abreu, Átila Pereira-Gonçalves, Andrelina Noronha Coelho-de-Souza, José Henrique Leal-Cardoso

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. A Bioactive Benzyl Terpene fromMolecules (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Diet of Broilers with Essential Oil fromAnimals : an open access journal from MDPI · 2023
    Article
  8. Review
  9. Use of Monoterpenes as Potential Therapeutics in Diabetes Mellitus: A Prospective Review.Advances in pharmacological and pharmaceutical sciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ana Carolina Cardoso-TeixeiraSuperior Institute of Biomedical Sciences, State University of Ceará, Fortaleza-CE 60741-903, Brazil. carol.cardoso@uece.br.
Francisco Walber Ferreira-da-SilvaCivil Engineering Department, State University of Vale do Acaraú, Sobral-CE 62042-280, Brazil. walber_ferreira@uvanet.br.
Dieniffer Peixoto-NevesDepartment of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA. dneves@uthsc.edu.ORCID 0000-0002-1190-5433
Klausen Oliveira-AbreuSuperior Institute of Biomedical Sciences, State University of Ceará, Fortaleza-CE 60741-903, Brazil. klausen.abreu@aluno.uece.br.
Átila Pereira-GonçalvesSuperior Institute of Biomedical Sciences, State University of Ceará, Fortaleza-CE 60741-903, Brazil. atila.pereira@aluno.uece.br.
Andrelina Noronha Coelho-de-SouzaSuperior Institute of Biomedical Sciences, State University of Ceará, Fortaleza-CE 60741-903, Brazil. andrelinanoronha@gmail.com.
José Henrique Leal-CardosoSuperior Institute of Biomedical Sciences, State University of Ceará, Fortaleza-CE 60741-903, Brazil. jose.cardoso@uece.br.
Universidade Estadual do Ceará · BRState University of Vale do Acaraú · BRUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study used isometric tension recording to investigate the vasorelaxant effect of limonene (LM), carveol (CV), and perillyl alcohol (POH) on contractility parameters of the rat aorta, focusing in particular on the structure-activity relationship. LM, CV, and POH showed a reversible inhibitory effect on the contraction induced by electromechanical and pharmacomechanical coupling. In the case of LM, but not CV and POH, this effect was influenced by preservation of the endothelium. POH and CV but not LM exhibited greater pharmacological potency on BayK-8644-induced contraction and on electromechanical coupling than on pharmacomechanical coupling. In endothelium-denuded preparations, the order of pharmacological potency on electrochemical coupling was LM < CV < POH. These compounds inhibited also, with grossly similar pharmacological potency, the contraction induced by phorbol ester dibutyrate. The present results suggest that LM, CV and POH induced relaxant effect on vascular smooth muscle by means of different mechanisms likely to include inhibition of PKC and IP3 pathway. For CV and POH, hydroxylated compounds, it was in electromechanical coupling that the greater pharmacological potency was observed, thus suggesting a relative specificity for a mechanism likely to be important in electromechanical coupling, for example, blockade of voltage-dependent calcium channel.

Indexed as

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAnimalsAorta, ThoracicCyclohexane MonoterpenesCyclohexenesIsometric ContractionLimoneneMolecular StructureMonoterpenesMuscle, Smooth, VascularPhenylephrinePhorbol 12,13-DibutyrateRatsStructure-Activity RelationshipTerpenesVasodilator Agents3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl estercarveolCyclohexane MonoterpenesCyclohexenesLimoneneMonoterpenesperillyl alcoholPhenylephrinePhorbol 12,13-DibutyrateTerpenesVasodilator Agentscarveollimoneneperillyl alcoholstructure-activity relationshipvascular smooth musclevasorelaxant effect

Identifiers

PMID29899230
PMCPMC6099955
OpenAlexW2808153675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.